Central Nervous System Embryonal Tumors

Area of Science:

• Pediatric neuro-oncology
• Neuroradiology
• Molecular pathology

Background:

• Central nervous system (CNS) embryonal tumors represent a group of aggressive pediatric brain cancers.
• These tumors are more prevalent in infants and young children, often presenting with disseminated disease and a poor prognosis.
• Despite shared aggressive features, specific clinical and imaging characteristics can aid in differentiating these entities.

Purpose of the Study:

• To review key diagnostic features of common and newly recognized CNS embryonal tumors.
• To highlight the role of imaging in the differential diagnosis of pediatric brain tumors.
• To provide an overview of current understanding of these aggressive pediatric neoplasms.

Main Methods:

• Literature review of central nervous system (CNS) embryonal tumors.
• Analysis of imaging characteristics, including enhancement patterns and peritumoral edema.
• Correlation of clinical factors such as patient age and tumor location with tumor type.

Main Results:

• Medulloblastoma, atypical teratoid rhabdoid tumor, and embryonal tumors with multilayered rosettes are reviewed.
• Newly recognized entities including CNS neuroblastoma, FOXR2-activated, and CNS tumor with BCOR internal tandem duplication are discussed.
• Imaging findings and patient demographics are crucial for distinguishing between these aggressive pediatric brain tumors.

Conclusions:

• Accurate diagnosis of CNS embryonal tumors relies on integrating clinical, imaging, and histopathological data.
• Understanding the spectrum of these tumors, including novel molecularly defined entities, is essential for appropriate management.
• Further research into the specific characteristics of these rare pediatric brain tumors is warranted.